FDA toughens warnings on Botox-like products

The Food and Drug Adminstration said Thursday that it is requiring makers of Botox and rival products to display tougher warnings on their labels advising the products may trigger certain dangerous side effects. The boxed warning is the strongest the FDA can impose on a prescription drug without asking it be withdrawn from the market.

Read full story via  MarketWatch.

Short URL: http://www.plasticsurgeonsnews.com/?p=231

Posted by admin on May 4 2009. Filed under Injectables. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry